How rigorous are the criteria used to conclude that complete differentiation of organ-specific stem cells to a heterologous lineage has occurred ... with available markers. If this were the ...

Other ADCs directed against other B-cell lineage antigens, including CD22, CD19 and CD70, are currently in Phase I/Phase II clinical trials. Early clinical data are encouraging. Important ...